Introduction
The mast cell carboxypeptidase A (MC-CPA)' enzymes of the rat, mouse, and human are homologous secretory granule metalloexopeptidases that have pH optima in the neutral to basic Address correspondence to Dr. Dale S. Reynolds range (1) (2) (3) . The MC-CPAs resemble bovine pancreatic carboxypeptidase A (CPA) in cleaving COOH-terminal aromatic and aliphatic amino acid residues, although human MC-CPA differs from bovine CPA by failing to cleave des-Arg bradykinin and substance P (4). MC-CPAs can cleave newly exposed COOH-terminal residues after endopeptidase cleavage by chymotryptic mast cell serine proteases, thereby sequentially degrading common protein substrates (5, 6) . Immunohistochemical analysis of human mast cells from various tissue sites has shown that MC-CPA epitopes are segregated to connective tissue phenotype mast cells prominent in gut submucosa and skin (7) , which also contain larger quantities of chymotryptic and tryptic serine proteases (8, 9) . In transformed mouse mast cell lines, the content ofMC-CPA enzymatic activity increases with differentiation toward the connective tissue mast cell phenotype (10) . Immature bone marrow-derived mouse mast cells obtained in vitro contain little MC-CPA in their granules, but they exhibit marked transcription of the MC-CPA gene (1 1), and greatly increase MC-CPA translation in response to coculture with mouse 3T3 fibroblasts (2) . MC-CPA mRNA expression in mouse mast cells obtained in vivo distinguishes among phenotypic subclasses in being high in connective tissue mast cells from the serosal cavity but absent to barely detectable in mucosal mast cell-rich tissue from the intestines of helminthinfected mice (12) .
The complete sequence of the human MC-CPA mRNA (13) was determined by cloning the cDNA from a human lung library using a mouse MC-CPA cDNA probe (11) , coupled with direct sequencing of the 5' end of the MC-CPA transcript in human lung poly(A)+ RNA. The complete deduced amino acid sequence of human MC-CPA revealed a 317 amino acid preproenzyme, which includes a 15 amino acid hydrophobic leader peptide, a 94 amino acid activation peptide, and a mature enzyme of 308 amino acids. Alignment of the deduced MC-CPA amino acid sequence with rat pancreatic carboxypeptidases Al (CPA1; 14), A2 (CPA2; 15) , and B (CPB; 14) showed overall amino acid sequence homologies of43, 43 , and 55%, respectively. The substrate-binding pocket residues of MC-CPA most closely resembled those of the pancreatic CPAs (13) .
Here we report the cloning and restriction endonuclease mapping of the 32-kb human MC-CPA gene, its complete DNA sequence except for gaps in the four largest introns, and its localization to human chromosome 3. Because the MC-CPA gene is the first carboxypeptidase gene to be characterized for any hematopoietic cell in general, and for the mast cell in particular, its organization was compared with the pancreatic carboxypeptidase genes, and its molecular ancestry was examined by an evolutionary analysis of the carboxypeptidase gene family. We also show by transcription analysis that this novel mammalian carboxypeptidase gene is normally substantially expressed only in mast cells as contrasted with other hematopoietic cell populations.
Methods
Cloning and structural characterization ofthe human MC-CPA gene. A human genomic DNA clone containing the 5' end of the human MC-CPA gene was previously isolated from a human genomic DNA library in the modified XEMBL-3 (SP6/T7) vector (HL1067J; Clontech Laboratories, Inc., Palo Alto, CA) (13) . To obtain clones containing the complete human MC-CPA gene, this library was screened with two human MC-CPA cDNA probes corresponding to the middle and 3' thirds of the 1,630-bp human MC-CPA cDNA sequence. The middleportion probe was a 585-bp 5'--oEcoRV fragment of a partial-length cDNA, corresponding to residues 489-1,073 of the complete human MC-CPA consensus cDNA sequence. The 3' probe was a 571-bp EcoRV--*3' cDNA fragment that lacked a poly(A) tail. These cDNAs were used sequentially to screen filters lifted from plating 1 X 106 recombinant phage. Filters were probed (11) at 370C and washed under conditions of high stringency (580C; 30 mM NaCl, 3 mM sodium citrate, 0.1% SDS, 1 mM EDTA, and 10 mM sodium phosphate, pH 7.0) to isolate 11 recombinants using the middle-portion cDNA probe, and 2 additional recombinants using the 3' probe. To obtain a preliminary map of the gene, restriction-digested X DNA (16) . Dispersed human lung cells were obtained from a 50-g human lung specimen by twice digesting minced tissue with pronase plus chymopapain, followed by two digestions with collagenase plus elastase (20) . After each digestion for 30 min at room temperature the minced lung tissue was passed over a Nytex filter; the free cells in the filtrate were pelleted and washed in Tyrode's buffer. Total RNA was isolated from 1.3 X 107 cells from the third filtrate, which were -10% mast cells containing granules that stained metachromatic with Toluidine blue. Human skin from a fresh surgical pathology specimen was minced with scissors on ice and homogenized in guanidine solution (21) in a blender for RNA isolation. PBMC (22) , plastic-adherent monocytes (23) , and neutrophils of > 95% purity (22) were obtained from healthy donors, as described. Hypodense eosinophils from a patient with hypereosinophilia secondary to experimental IL-2 tfierapy for a malignancy were obtained by isolation of PBMC followed by culture in enriched medium plus 10 pM recombinant human GM-CSF to further select for eosinophils (24 (13) . This library was rescreened with two partial-length MC-CPA cDNA probes that corresponded to approximately the middle and 3' thirds ofthe MC-CPA transcript to obtain 11 and 2 additional recombinant phage clones, respectively. To obtain a preliminary map and determine which ofthe 14 clones would be sufficient to span the entire MC-CPA gene, blots containing restriction-digested X phage DNA from each ofthe clones were probed with radiolabeled oligonucleotides which were predicted to correspond to putative exons 1, 2, 3, 4, 6, 9, 10, or 11 of the MC-CPA gene, based on alignment of the MC-CPA cDNA sequence with the rat CPB gene. Four clones, designated XgHMCCPA-l to -4, were predicted to contain inserts that spanned putative exons 1-3, 3-9, 4-10, and 10-11, respectively, ofthe MC-CPA gene. From detailed restriction mapping of these four clones a map of the complete human MC-CPA gene was constructed (Fig. 1) . The restriction sites present in the overlapping recombinant phage inserts were consistent with a previous genomic DNA blot analysis using a full-length MC-CPA cDNA probe (13) .
With the exception of gaps in the four largest introns, the nucleotide sequence of the complete human MC-CPA gene ( Fig. 2 A) was determined including 1,800 bp on the 5' flank ( Fig. 2 B) . By comparison with the consensus nucleotide sequence for the complete MC-CPA mRNA obtained from cDNA and direct mRNA sequencing (13), the human MC-CPA gene was determined to have 11 exons spanning 32 kb. No differences were noted between the consensus MC-CPA cDNA sequence and the combined sequences ofthe exons. The TATAAA-like sequence CATAAA is present 31 bp 5' to the major transcription initiation site ( 13) . Exons (14), CPA2 (15) , and CPB (14) . With the exception of intron 3 (see below) the MC-CPA and pancreatic carboxypeptidase genes have similar overall organizations, although the lengths ofcorresponding introns and total lengths of the genes vary considerably. To obtain a detailed comparison of the intron/exon organization of the MC-CPA gene with the pancreatic carboxypeptidase genes, amino acid sequences for the five known prepropeptides (Fig. 4 A) and for the mature enzymes of 10 members of the carboxypeptidase gene family (Fig. 4 B) were aligned. This alignment was used to compare the relative positions of the introns for the MC-CPA and pancreatic carboxypeptidase genes. Intron numbers are designated above the corresponding amino acid residues in Fig. 4 , A and B. For the MC-CPA and rat CPA1, CPA2, and CPB genes, all intron/exon junctions occur at homologous amino acid codons, except for intron 3. Furthermore, in almost every case, corresponding introns for the four genes fall after the same nucleotides of the codons. Intron 3 of the human MC-CPA gene occurs at a site homologous to that of intron 3 of the rat CPB gene, after the second nucleotide of the Glu (E) codon at amino acid position -20 -100 ( Fig. 4 A) . In contrast, codons for an additional seven amino acids (IMIEDVQ) precede intron 3 in the CPA2 gene (15) . These same seven amino acids are found in the large exon 3 of the CPA1 gene, but no equivalent third intron is present ( 14) . For the 10 aligned mature carboxypeptidase amino acid sequences (Fig. 4 B) , 34 amino acid residues were completely invariant. Based on x-ray crystallographic studies (33, 34) of bovine CPA (35) and CPB (36) , several of the invariant residues correspond to predicted zinc-binding, and catalytic and substrate-binding amino acids.
RNA blot analysis using a gene-specific probefor MC-CPA. Similar-sized 1.7-kb MC-CPA transcripts were detected in poly(A)+ RNA from lung ( Fig. 4 A) . The small, horizontally barred area (inset) represents seven amino acids, IMIEDVQ, present in exon 3 of CPA 1 and CPA2 (see Fig. 4 A) . The gene structures for CPA 1, CPA2, and CPB are taken from Clauser et al. (14) and Gardell et al. (15) .
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EliZ. i D Using MC-CPA cDNA probes the complete 32-kb MC-CPA gene was isolated, restriction mapped (Fig. 1) , subcloned into plasmids, and partially sequenced (Fig. 2, A and B) . The 11 exons of the MC-CPA gene contained a short, 1-nucleotide 5'-untranslated region followed by the coding sequences for the leader peptide (within exon 1), activation peptide (exons 1-4), and mature enzyme (exons 4-1 1). Based on x-ray crystallographic studies (33, 34) of bovine CPA. (35) and CPB (36) , predicted zinc-and substrate-binding amino acid residues of MC-CPA are distributed over several exons. The predicted zinc-binding residues corresponding to His69, Glu72, and His'96 of bovine CPA are in exons 6, 6, and 9, respectively, whereas catalytic and substrate-binding residues corresponding to Arg7 , Arg'27, Asn'", Arg'45, Tyr'98, Asp26 Glu270I and Phe279 of bovine CPA are in exons 6, 8, 8, 8, 9 , 1 1, 1 1, and 1 1, respectively.
The intron/exon organization ofthe MC-CPA gene (Fig. 3 ) was compared with the pancreatic carboxypeptidase genes by determining the relative positions of intron breakpoints in the aligned preproenzyme amino acid sequences (Fig. 4, A and B) . With the exception ofintron 3, placement ofintrons was highly conserved, indicating that this gene family derived from a single primordial carboxypeptidase gene. The splice junction for intron 10 ofthe MC-CPA gene occurs within the codon for the predicted substrate-binding residue Tyr247 (Tyr24" of bovine CPA). Splice sites often are located at codons for surface residues, where a junctional mutation may not significantly alter protein structure (37) . Tyr21 of bovine CPA may have arisen by a junctional mutation early in carboxypeptidase evolution and then been conserved, as it is an invariant residue in the carboxypeptidase gene family (Fig. 4 B) and occurs at the splice junction for intron 10 in all four carboxypeptidase genes (14, 15 (14) . The corresponding region in the CPA2 (15), CPB (14) , and MC-CPA genes is divided by intron 3 (see Fig. 3 , inset). Intron 3 in the CPA1 gene must have been deleted after a gene duplication leading to separate CPA1 and CPA2 genes. Examples have been described of precise intron loss in members of other gene families (38, 39) . Intron loss may occur by homologous recombination with a DNA copy ofthe spliced transcript, as in pseudogene formation (40) . Figure 6 . Minimal nucleotide replacement tree for the 10 carboxypeptidase amino acid sequences shown in Fig. 4 . Numbers on the branches represent the least number of nucleotide substitutions that could give rise to the amino acid sequences at the tips. There are four groups of orthologues ( [1] [2] [3] , [4, 5] , [6, 7] , and [8] To establish the molecular ancestry of MC-CPA within the carboxypeptidase gene family, an evolutionary tree was constructed for the 10 mature carboxypeptidase amino acid sequences, using the Fitch algorithm for generation of minimal nucleotide replacement trees from amino acid sequence data (53). The most parsimonious nucleotide replacement tree that could give rise to the different amino acid sequences is shown in Fig. 6 . The number of nucleotide substitutions required to give the amino acid sequences are shown, and are depicted as the lengths of the branches. There are four groups of orthologues ( [1] [2] [3] , [4, 5] , [6, 7] , and [8] ), representing four modern mammalian carboxypeptidase genes and their species homologues. These groups are paralogous to each other, arising from three gene duplications at A, B, and I. In tree I, the crayfish CPB lineage diverges before separate A and B groups are formed by gene duplication. A common MC-CPA/CPB ancestor diverged from the lineage leading to CPA by a gene duplication, and then underwent a second duplication to form separate but similar MC-CPA and CPB gene structures as defined by intron/exon organization. Distinct ancestors of these three modern mammalian carboxypeptidase genes, CPA, CPB, and MC-CPA, were established before the radiation of mammalian species which began 100 million years ago (40) . Because the mouse, rat, and human MC-CPAs all have a Leu residue at the critical specificity-determining position corresponding to Ile2" of bovine CPA, conversion of this residue to a Leu in the lineage leading to the MC-CPAs probably occurred before mammalian speciation as well.
Using a gene-specific MC-CPA cDNA probe under conditions of high stringency, similar-sized MC-CPA transcripts are present in poly(A)+ RNA from lung and skin tissues, and in total RNA from dispersed lung cells enriched to contain 10% mast cells (Fig. 5) . In transformed cell lines MC-CPA mRNA was barely detectable in poly(A)+ RNA from one of three T lymphoblastic tumor cell lines, and was also detected in three granulated tumor lines of bone marrow origin: the megakayocytic cell line CMK and two immature myelomonocytic cell lines, HL-60 and KG-1 (54, 55) . None ofseveral purified, nontransformed cell populations contained detectable MC-CPA mRNA, including neutrophils, eosinophils, monocytes, NK cells, unfractionated PBMC, polyclonal T lymphocytes, and cloned CTL lines. Therefore MC-CPA mRNA is a specific molecular marker for mast cells among normal hematopoietic cell populations.
